Patent details

EP2536734 Title: FORMS OF RIFAXIMIN AND USES THEREOF

Basic Information

Publication number:
EP2536734
PCT Application Number:
PCT/US/2011/024981
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117451344
PCT Publication Number:
WO/2011/103120
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMS OF RIFAXIMIN AND USES THEREOF
French Title of Invention:
FORMES DE RIFAXIMINE, ET LEURS UTILISATIONS
German Title of Invention:
FORMEN VON RIFAXIMIN UND ANWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
16/02/2011
Grant date:
31/08/2016
EP Publication Date:
31/08/2016
PCT Publication Date:
25/08/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/12/2012
EP B1 Publication Date:
31/08/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/02/2017
Expiration date:
16/02/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/10/2016
 
 

Name:
Salix Pharmaceuticals Ltd.
Address:
400 Somerset Corporate Blvd., Bridgewater, NJ 08807, United States (US)

Inventor

1

Name:
YANG Donglai
Address:
United States (US)

2

Name:
STULTS Jeffrey, S.
Address:
United States (US)

3

Name:
VLAHOVA Petinka
Address:
United States (US)

4

Name:
GUSHURST Karen, S.
Address:
United States (US)

Priority

Priority Number:
708836
Priority Date:
19/02/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 498/22;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages